Quick answer: The vape4sale.com FDA warning letter alleges that the online retailer sold a Flum UT 50,000 Puffs Vape product to a person younger than 21 during an FDA investigation. VapeRisk reads the letter as a retail compliance signal: online age-gating, product authorization, and supplier documentation all need to be checked together.
| Field | Detail |
|---|---|
| Event | FDA warning letter to vape4sale.com |
| Date | May 15, 2026 |
| Agency | FDA Center for Tobacco Products |
| Product named | Flum UT 50,000 Puffs Vape – Slushy Lemon |
| Allegation | Sale of a tobacco product to a person younger than 21 |
| Retail relevance | Online checkout controls can become an enforcement issue even before broader product-authorization questions |
What happened
FDA issued a warning letter to vape4sale.com dated May 15, 2026. The letter says FDA reviewed the website and determined that ENDS products were offered for sale or distribution to consumers in the United States.
The letter specifically alleges that a Flum UT 50,000 Puffs Vape – Slushy Lemon ENDS product was sold to a person younger than 21 during FDA’s investigation. FDA also reminded the recipient that new tobacco products require premarket authorization unless they otherwise fall within a legally marketable category.
Why the vape4sale.com FDA warning letter matters
Online vape retail is often discussed as a product-listing problem: whether the SKU is authorized, whether the label is accurate, or whether the seller can document supply. This warning letter adds another layer. The checkout process itself can be the enforcement trigger.
That matters for high-puff disposables because the same product pages often combine aggressive puff-count claims, bright flavor language, and fast checkout flows. A retailer may face risk from both the product claim and the age-verification workflow.
VapeRisk risk read
VapeRisk would treat this as a retail-shelf and online-cart risk story, not a product review. The letter does not prove the named product’s real puff count, battery performance, or lab profile. It does show that online retail systems need evidence of Tobacco 21 compliance, not just a generic “21+” banner.
What buyers or retailers should watch
- Whether the site verifies age before purchase, not only at homepage entry.
- Whether the listed product has searchable authorization evidence.
- Whether product pages use high-puff and flavor claims without adequate compliance context.
- Whether a retailer keeps records for checkout controls, shipment controls, and product intake.
What remains unverified
The warning letter is FDA’s allegation and compliance notice. It is not a final court judgment. The letter also does not independently verify whether the named product can deliver 50,000 puffs.
Related VapeRisk Coverage
- Retail shelf risk is the new vape media beat
- What retailers should ask before stocking a new vape SKU
- How high-puff disposables changed the review problem
FAQ
What did the vape4sale.com FDA warning letter allege?
The vape4sale.com FDA warning letter alleged that an ENDS product was sold online to a person younger than 21 during FDA’s investigation.
Which product did FDA name?
FDA named a Flum UT 50,000 Puffs Vape – Slushy Lemon ENDS product in the warning letter.
Does a 21+ homepage notice solve online vape compliance?
No. A homepage notice alone is not enough evidence. Online retailers need controls that support age compliance through the purchase and fulfillment workflow.